TITLE

J&J Makes Play for Cougar Biotech

AUTHOR(S)
Marino, Jonathan
PUB. DATE
May 2009
SOURCE
Mergers & Acquisitions Report;5/25/2009, Vol. 22 Issue 21, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the acquisition of Cougar Biotechnology by Johnson & Johnson, a global pharmaceutical and retail products company. It states that Cougar will be acquired for nearly 1 billion U.S. dollars or about 43 U.S. dollars per share. Cougar is a developer of products to treat prostate and breast cancer.
ACCESSION #
44148502

 

Related Articles

  • J&J Captures Cougar in $970M Purchase.  // Bioworld Week;6/1/2009, Vol. 17 Issue 22, p2 

    The article reports on the acquisition of Cougar Biotechnology Inc. by Johnson & Johnson (J&J) for only $970 million in the U.S. in 2009. The acquisition is intended to enable J&J develop treatment for breast cancer and multiple myeloma. Spokesman of J&J Bill Price affirms that the acquisition...

  • JNJ Captures Cougar in $970M Purchase. Hollingsworth, Catherine // BioWorld Today;5/26/2009, Vol. 20 Issue 99, p1 

    This article reports on the decision of Johnson & Johnson to buy Cougar Biotechnology Inc. in 2009. With the purchase, Johnson & Johnson aims to strengthen its oncology portfolio. Cougar would maintain its employees and offices in Los Angeles, California, under a deal. The transaction was...

  • Follow-Up on Monitored Stocks.  // Dow Theory Forecasts;6/1/2009, Vol. 65 Issue 22, p6 

    The article offers updates on the related to stocks from different industry group worldwide. Aflac Inc.'s shares have tumbled due to unreliable scoundrel in its investment portfolio. St. Jude Medical Inc. has been recommended in the buy list despite earning a Quadrix overall score of 74. Johnson...

  • CORPORATE.  // MondayMorning;12/6/2010, Vol. 18 Issue 45, p2 

    The article offers information on several business enterprises related to pharmaceutical industry. It states that company GE Healthcare and Johnson and Johnson are teaming up in a research agreement to find biological signals for Alzheimer's disease and its therapeutics. It reports on the...

  • J&J completes initial tender offer for Cougar Biotechnology.  // PharmaWatch: Biotechnology;Aug2009, Vol. 8 Issue 8, p26 

    The article reports on the completion on the initial tender offer by pharmaceutical company Johnson & Johnson (J&J) for all outstanding shares of common stock of Cougar Biotechnology Inc., a biopharmaceutical products developer in the U.S. The depositary for the offer gives J&J nearly 17.74...

  • OTC: REPORTERS Notebook.  // Drug Store News;1/15/2007, Vol. 29 Issue 1, p49 

    The article reports on the acquisition of Pfizer Inc. by Johnson & Johnson Inc. (Johnson & J) in December 2006 in the U.S. With the effort, Johnson & J Consumer Group portfolio will feature products including Listerine oral care products, Nicorette line of smoking cessation treatments and...

  • More Biotech Deal-Making Ahead? Mullin, Rick // Chemical Week;4/3/2002, Vol. 164 Issue 14, p26 

    Reports on the acquisition of biotechnology firms by pharmaceutical companies Johnson & Johnson and Schering. Details on the biotechnology firms acquired by the two companies; Risks involved in acquiring biotechnology firms; Reasons for the acquisitions.

  • CORPORATE.  // MondayMorning;6/22/2009, Vol. 17 Issue 23, p2 

    The article offers business related news briefs. WebMD Health Corp. will merge itself with Hlth Corp. following an all-stock deal worth $1.29 billion. Watson Pharmaceuticals Inc. has agreed to purchase Arrow Group A/S for $1.75 billion in stock and cash. The company Johnson & Johnson has...

  • Time to Rethink the Rules of Biotech? Maybe, Maybe Not. Thiel, Karl // BioWorld Today;6/8/2009, Vol. 20 Issue 108, p1 

    The author highlights a few events that occurred in the biotechnology industry in May 2009 that caused him to rethink some preconceived notions. He points out the growing popularity of reverse mergers as making initial public offering (IPO) becomes difficult. Particular focus is given to the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics